UnitedHealth Group Incorporated (UNH)
NYSE: UNH · Real-Time Price · USD
466.42
-36.00 (-7.17%)
At close: Feb 21, 2025, 4:00 PM
465.98
-0.44 (-0.09%)
After-hours: Feb 21, 2025, 7:59 PM EST
UnitedHealth Group Stock Forecast
Stock Price Forecast
The 20 analysts with 12-month price forecasts for UnitedHealth Group stock have an average target of 623.6, with a low estimate of 460 and a high estimate of 700. The average target predicts an increase of 33.70% from the current stock price of 466.42.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for UnitedHealth Group stock from 21 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
---|---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
Buy | 10 | 11 | 11 | 11 | 12 | 12 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 19 | 20 | 20 | 20 | 21 | 21 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wells Fargo | Wells Fargo | Buy Maintains $694 → $660 | Buy | Maintains | $694 → $660 | +41.50% | Jan 28, 2025 |
Barclays | Barclays | Buy Maintains $655 → $642 | Buy | Maintains | $655 → $642 | +37.64% | Jan 17, 2025 |
Keybanc | Keybanc | Buy Reiterates $650 | Buy | Reiterates | $650 | +39.36% | Jan 17, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $700 | Buy | Reiterates | $700 | +50.08% | Jan 17, 2025 |
Truist Securities | Truist Securities | Strong Buy Maintains $625 → $610 | Strong Buy | Maintains | $625 → $610 | +30.78% | Jan 6, 2025 |
Financial Forecast
Revenue This Year
454.53B
Revenue Next Year
491.00B
from 454.53B
Increased by 8.02%
EPS This Year
30.03
from 15.51
Increased by 93.66%
EPS Next Year
33.84
from 30.03
Increased by 12.69%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 480.3B | 523.5B | 575.4B | ||
Avg | 454.5B | 491.0B | 531.0B | ||
Low | 419.6B | 452.5B | 491.8B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | 15.2% | 17.2% | ||
Avg | - | 8.0% | 8.1% | ||
Low | - | -0.4% | 0.2% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 31.73 | 36.00 | 41.63 | ||
Avg | 30.03 | 33.84 | 38.44 | ||
Low | 28.67 | 31.38 | 34.66 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 104.6% | 19.9% | 23.0% | ||
Avg | 93.7% | 12.7% | 13.6% | ||
Low | 84.9% | 4.5% | 2.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.